Email: lixifirm@outlook                       whatsapp:+8618273793022

High-Purity Manganese Dioxide for Pharmaceutical Synthesis

Short Product Description

High-purity manganese dioxide (MnO₂) ≥98% for pharmaceutical synthesis. Ideal for organic oxidation and dehydrogenation reactions requiring consistent reactivity and low impurities. Suitable for research and industrial-scale chemical production.

manganese dioxide supplier

Technical Specifications

PropertyTypical RangeUnit
MnO₂ content98–99%
Moisture≤0.5%
Particle size (D50)5–20μm
Loss on ignition≤0.5%
Bulk density0.8–1.2g/cm³
Impurities (Fe, Al, Pb, Cd)≤0.01%

Key Features

  • Ultra-high purity ≥98% for precise chemical synthesis

  • Controlled particle size for uniform reaction rates

  • Low moisture and minimal heavy metal impurities

  • Stable performance under industrial conditions

  • Easy to handle and disperse in organic solvents

Applications

  • Pharmaceutical synthesis – suitable for oxidation and dehydrogenation reactions

  • Organic chemical reactions – provides consistent reactivity

  • Research laboratories – ensures reproducible experimental results

  • Fine chemicals production – low impurity grade prevents side reactions

What Problems Do We Solve?

1. Inconsistent Reaction Selectivity in Alcohol Oxidation

Many pharmaceutical synthesis processes rely on selective oxidation of allylic and benzylic alcohols to aldehydes or ketones. Low-grade MnO₂ often contains mixed oxides and impurities that cause side reactions.

Solution

High-purity MnO₂ provides:

  • Selective oxidation efficiency >90%

  • Minimal over-oxidation

  • Cleaner reaction pathways

This improves yield stability and product purity, which is critical in pharmaceutical intermediate synthesis.

2. Heavy Metal Contamination Risks

Pharmaceutical production must comply with strict impurity limits. Technical-grade manganese dioxide may introduce trace metals such as Fe, Cu, or Pb that can contaminate intermediates.

Solution

High-purity MnO₂ features:

  • Controlled heavy metal content (typically <50 ppm total impurities)

  • Reduced risk of contamination in APIs and intermediates

  • Easier compliance with GMP and regulatory standards

This helps pharmaceutical manufacturers maintain regulatory compliance and product safety.

3. Poor Reproducibility Between Batches

Inconsistent particle size and surface activity in standard MnO₂ grades can lead to unstable reaction kinetics.

Solution

High purity manganese dioxide provides:

  • Controlled particle size distribution (typically 5–20 µm)

  • Stable surface activity

  • Consistent oxidation performance across batches

This ensures reproducible reaction conditions in laboratory and scale-up synthesis.

  1. 4. Difficult Filtration and Downstream Processing

Some oxidants create soluble residues or difficult purification steps.

Solution

MnO₂ acts as a heterogeneous oxidant:

  • Solid catalyst easily removed by filtration

  • Minimal downstream purification

  • Reduced solvent consumption

This improves process efficiency and reduces operational cost.

5. Over-Oxidation of Sensitive Molecules

Pharmaceutical intermediates often contain sensitive functional groups that can be destroyed by strong oxidants.

Solution

MnO₂ operates under mild reaction conditions (20–60 °C) and shows strong functional group tolerance.

This allows:

  • Controlled oxidation

  • Protection of sensitive structures

  • Higher product purity.

Packaging & Supply

  • Available in 25 kg, 50 kg, and 500 kg bags

  • Suitable for export with standard documentation

  • Bulk and custom packaging upon request

Customization & Technical Support

  • Particle size and purity adjustable to specific requirements

  • Full technical support for reaction optimization and scale-up

FAQ

1. What purity level of manganese dioxide is required for pharmaceutical synthesis?

Most pharmaceutical synthesis applications require high-purity MnO₂ above 90–95%, with strict control of heavy metals and other impurities to ensure reaction selectivity and regulatory compliance.

2. What reactions commonly use MnO₂ in pharmaceutical manufacturing?

MnO₂ is widely used for:

  • Oxidation of allylic alcohols to aldehydes

  • Oxidation of benzylic alcohols to ketones

  • Late-stage oxidation in organic synthesis

  • Preparation of pharmaceutical intermediates

These reactions benefit from MnO₂’s high selectivity and mild conditions.

3. How does particle size affect MnO₂ performance?

Particle size directly affects oxidation efficiency.

Typical specifications:

ParameterTypical Range
Particle Size (D50)5–20 µm
Smaller particlesFaster reaction rate
Larger particlesEasier filtration

Most fine chemical producers prefer balanced particle size (~10–15 µm) to optimize both activity and filtration.

4. Can MnO₂ be used as a catalyst or only as an oxidant?

MnO₂ can function as:

  • Stoichiometric oxidant

  • Heterogeneous oxidation catalyst

  • Reaction promoter in organic synthesis

Its dual role makes it valuable in laboratory and industrial pharmaceutical synthesis.

5. Is high-purity MnO₂ suitable for scale-up production?

Yes. High-purity MnO₂ is commonly used from:

  • laboratory R&D

  • pilot scale synthesis

  • industrial pharmaceutical intermediate production

Consistent particle size and purity ensure reliable performance during process scale-up.

High-Purity Manganese Dioxide for Pharmaceutical Synthesis

Ultra-high purity Pharmaceutical Grade Manganese Dioxide (MnO₂ ≥ 98%) specifically refined for API synthesis and pharmaceutical intermediates. This premium reagent features extremely low heavy metal content (Fe, Pb ≤ 0.01%) and a controlled particle size (D50 2-10 μm) to ensure high selectivity and consistent yields in sensitive organic oxidation reactions.

Product SKU: MnO2-PHARMA-98

Product Brand: BTL New Material

Product In-Stock: InStock

Editor's Rating:
5